| Document |
Document Title |
|
WO/2024/068553A1 |
The present invention relates to tertiary amide compounds of formula (II), or a pharmaceutically acceptable salt thereof, wherein R7 comprises a group X which is -S(=O)2OH, -S(=O)OH or -P(=O)(OH)2- The compounds are capable of solubilizi...
|
|
WO/2024/056678A1 |
The present invention relates to compounds according to formula (I), which are prodrugs of the psychoactive compound phenethylamine or its derivatives. The prodrugs provided herein exhibit improved pharmacokinetic properties during uptak...
|
|
WO/2024/023360A1 |
The present invention provides IP5 substituted compounds of general formula I, their methods of synthesis and their uses. The IP5 substituted compounds of the invention are characterized for having -O(alkyl)nX, and -O(alkyl)yCy(alkyl)y'-...
|
|
WO/2024/013196A1 |
The application provides a process for recovering purified ε-caprolactam from nylon 6-containing multi-component material which comprises the steps of a) providing a pre-concentrated nylon 6-containing material obtained by extraction, b...
|
|
WO/2024/000849A1 |
The present invention provides a method for synthesizing caprolactam by means of a Beckmann rearrangement reaction. In the method, by designing a special process route, selecting a specific solvent, and dissolving reactants with the solv...
|
|
WO/2024/000848A1 |
Provided in the present invention is a caprolactam synthesis method free of by-production of ammonium sulfate. By designing a special process route, selecting a specific solvent, and using cyclohexanone oxime as a raw material, a Beckman...
|
|
WO/2023/248205A1 |
The subject of the invention is a novel ruthenium complex with the general formula Ru-1, in which all the variables have the meaning defined in the disclosure. The subject of the invention is also a synthesis method of the ruthenium comp...
|
|
WO/2023/248117A2 |
The present invention relates to a temperature integrity sensor or more precisely a temperature continuity sensor of a product which needs to be kept at a temperature below its degradation temperature, such as for instance a refrigerated...
|
|
WO/2023/205269A1 |
The present invention relates to electrochromic devices and compositions, which include a cathodic component that includes cathodic zwitterions, where an anion is covalently bonded by a divalent linking group to a pyridinium nitrogen of ...
|
|
WO/2023/205336A1 |
The present invention relates to electrochromic devices and compositions, in which the cathodic component has cationic charge and includes counter-anions, where each counter-anion of the cathodic component is an anodic component having a...
|
|
WO/2023/187043A1 |
The present invention relates to a water-efficient process for hydrolytically depolymerizing a polyamide prepared from ε-caprolactam.
|
|
WO/2023/187045A1 |
The present invention relates to a process for hydrolytically depolymerizing a polyamide prepared from ε-caprolactam and an apparatus for carrying out a process for hydrolytically depolymerizing a polyamide prepared from ε-caprolactam.
|
|
WO/2023/187049A1 |
The present invention relates to a process for separating at least one ε-caprolactam oligomeric compound CPO from a stream SR comprising said at least one CPO and ε-caprolactam monomeric compound CPM.
|
|
WO/2023/187036A1 |
The present invention relates to a heat-integrated process for hydrolytically depolymerizing a polyamide prepared from ε-caprolactam, said polyamide being contained in a solid material M.
|
|
WO/2023/144337A1 |
The present invention provides an improved process for the recovery of ε-caprolactam from Nylon 6 comprising multi-component material, in particular multi-layered film. Further, the invention provides a plant configured to carry out the...
|
|
WO/2023/144338A1 |
The present invention provides a process and a plant for recovering purified ε-caprolactam from polyamide 6 comprising fishing nets, wherein the plant comprises a depolymerization section [B], a recovery section [C], and a purification ...
|
|
WO/2023/144339A1 |
The present invention provides a process and a plant for recovering purified E-caprolactam from nylon 6 comprising fishing nets, wherein the plant comprises a depolymerization section [B], a recovery section [C], and a purification secti...
|
|
WO/2023/083465A1 |
A P2S5·2C5H5N stock formulation comprising a solution of P2S5·2C5H5N in sulfolane, a process for preparing the formulation, and the use of the formulation in a thionating reaction.
|
|
WO/2023/073634A1 |
Compounds containing the carbamoselenoyl and/or sulfamoyl function, usable as selective antifungal agents against Malassezia pachydermatis strains for topical veterinary and human use, having the following general structures: Formula I; ...
|
|
WO/2023/074432A1 |
Provided is a green, energy-saving production method that achieves both re-utilization of a fossil resource and reduction of greenhouse gas emissions in a method for producing ε-caprolactam from a polyamide 6 resin composition. The pres...
|
|
WO/2023/074438A1 |
Provided is a method for producing a thermoplastic resin by using ε-caprolactam obtained by performing depolymerization of a waste product of a polyamide 6 resin composition molded article by using only a small amount of water, etc., an...
|
|
WO/2023/074433A1 |
Provided is a method for recovering a highly pure fibrous filler and ε-caprolactam from a polyamide 6 resin composition, which contains the fibrous filler, only by solid-liquid separation. The present invention pertains to a method for ...
|
|
WO/2023/072199A1 |
The present invention relates to the field of caprolactam production. Disclosed is a method for producing high-purity ε-caprolactam. The method comprises the following steps: (1) carrying out a gas-phase Beckmann rearrangement reaction ...
|
|
WO/2023/074441A1 |
Provided is a green, energy-conserving method for producing ε-caprolactam from a polyamide 6 resin composition, wherein said method achieves both fossil resource recycling and a reduction in greenhouse gas emissions. The present inventi...
|
|
WO/2023/074437A1 |
The present invention provides a recovery method with less energy consumption, the recovery method being capable of recovering ε-caprolactam and a polyamide 6 oligomer with high yield by depolymerization with use of a little water and s...
|
|
WO/2023/014938A1 |
The present disclosure provides linker compounds of Formula (I) or (II) pharmaceutically acceptable salts thereof, and related scaffolds and conjugates. More specifically, linker compounds of formulas (l-A), (Il-A) are provided: The pres...
|
|
WO/2023/009330A1 |
The invention describes novel serotonin c5-HT2B receptor antagonists of Formula (1), and pharmaceutically acceptable salts thereof; wherein Ring A, L, X, X', R3, (1) R4, m and n are as defined herein. Also described are compositions comp...
|
|
WO/2023/004356A2 |
The present disclosure relates to new and useful azaindole cyanine (pyrrolo pyridine cyanine) compounds. Use of the compounds as dyes that operate in the far-red and near-IR spectral region in biological imaging, and methods of making th...
|
|
WO/2023/281126A2 |
The present invention relates to a compound of formula (I), to its use in electronic devices, to methods for producing said compound, and to electronic devices containing the compound.
|
|
WO/2022/264069A1 |
Methods of preparing compounds useful as water soluble dyes are disclosed. Specifically, the compounds have the following Structure (I): (I) or a stereoisomer, tautomer or salt thereof, wherein L1, L2, L3, R1, R2, and M are as defined he...
|
|
WO/2022/248635A2 |
The present disclosure relate to a method for producing a tryptamine derivative of formula (I), wherein the tryptamine derivative (I) is not tryptophane, 4-hydroxytryptamine, N-acetyl-4-hydroxytryptamine, norbaeocystin, baeocystin; psilo...
|
|
WO/2022/226416A1 |
The present disclosure provides photo-polymerizable monomers, photo-curable resins comprising one or more of such monomers, as well as polymeric materials formed from the photo-curable resins. Further provided herein are methods of produ...
|
|
WO/2022/214703A2 |
The invention relates to a method of identifying selective covalently binding inhibitors by using a reversibly inhibiting scaffolds modified by a warhead comprising a fast-reacting Michael acceptor moiety and a linker of different length...
|
|
WO/2022/207312A1 |
The field of the disclosure lies in active materials for organic image sensors. The present disclosure relates to indacenetetrone-based active materials and their use in photoelectric conversion layer(s) and/or an organic image sensor an...
|
|
WO/2022/158872A1 |
The present invention relates to a purification method for laurolactam, and more specifically, to a purification method capable of obtaining high-purity laurolactam substantially free of impurities. The present invention provides a metho...
|
|
WO/2022/129595A1 |
A material comprising an electron-accepting unit of formula (I): Ar is an aromatic ring; Ar1 is a substituted or unsubstituted 5- or 6-membered heteroaromatic ring containing N and C ring atoms; when Ar1 is a substituted or unsubstituted...
|
|
WO/2022/079067A1 |
The present invention relates to cyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
|
|
WO/2022/053660A2 |
The use of an N-heterocyclic compound of the general formula (a) or (b) with the following definitions: X1 being S or O, X2 being S or O and at least one of X1 and X2 being S R2 H or C1-4-alkyl, R3 H or C1-4-alkyl R6 and R7 are hydrogen ...
|
|
WO/2022/020547A1 |
An improved method is disclosed for preparing an organic pesticide of Formula 4-A from (1) a composition comprising: (a) a crystalline organic pesticide; (b and c) compounds of Formulae 1 and 2; (d) an amine base and (e) an aprotic solve...
|
|
WO/2021/214348A2 |
The invention relates to compounds of formula (I), to methods for the preparation of said compounds, to the use of said compounds in electronic devices and to electronic devices containing at least one of said compounds.
|
|
WO/2021/208201A1 |
The present invention provides an external micro-interface ammoximation reaction system and method. The external micro-interface ammoximation reaction system comprises an oximation reactor, a reaction clear liquid buffer tank, a tert-but...
|
|
WO/2021/208200A1 |
The present invention provides a built-in micro-interface ammoximation reaction system and method, the system comprising an oximation reactor, a reaction supernatant buffer tank, a tert-butanol recovery tower, an extraction tank, a water...
|
|
WO/2021/156371A1 |
The invention provides a process for the production of crystalline ammonium sulfate, wherein the process comprises performing a Beckmann rearrangement reaction, neutralizing the Beckmann rearrangement reaction mixture, separating a first...
|
|
WO/2021/119004A1 |
A process for the synthesis of N-alkylated lactams via reductive alkylation. The process of the present disclosure may be conducted by the addition of an aldehyde to a lactam in the presence of a catalyst under a reducing atmosphere.
|
|
WO/2021/112407A1 |
The present invention relates: a method for producing laurolactam, the method comprising a) a step for synthesizing cyclododecanone oxime into laurolactam through Bechmann rearrangement in a catalytic system, b) a step for mixing the lau...
|
|
WO/2021/100759A1 |
The present invention synthesizes ε-caprolactam from 5-cyanovaleramide with high yield by means of the steps (A) and (B) described below. (A) a step for obtaining 5-cyanovaleramide hydrogenation reaction mixture by causing 5-cyanovalera...
|
|
WO/2021/094184A1 |
The invention provides a process and a plant for the production of ε-caprolactam and crystalline ammonium sulfate in an industrial-scale plant, wherein the plant comprises a Beckmann rearrangement reaction section, an ammonium sulfate c...
|
|
WO/2021/085653A1 |
The present invention provides an antitumor agent comprising a compound or a pharmaceutically acceptable salt thereof that covalently binds to GTP-bound KRASG12C as an active ingredient.
|
|
WO/2021/067836A1 |
The disclosure provides therapeutic compositions (i.e., therapeutic agents) and methods of preventing or treating Friedreich's ataxia in a mammalian subject, reducing risk factors, signs and/or symptoms associated with Friedreich's ataxi...
|
|
WO/2021/024256A1 |
The invention generally concerns a method for conjugating an active material to a Pt complex.
|
